May 23, 2022
In 2021, there are 89 Chinese biomedical companies (according to the classification of "Pharmaceutical and Biological" based on the industry division method of Shenyin & Wanguo Securities) completed IPOs in the Chinese mainland, Hong Kong Region of China,